Davis's Drug Guide
Breo Ellipta 100/25
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Breo Ellipta 100/25." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110713/0/Breo_Ellipta_100_25.
Vallerand AHA, Sanoski CAC, . Breo Ellipta 100/25. Davis's Drug Guide. F.A. Davis Company; 2025. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110713/0/Breo_Ellipta_100_25. Accessed January 22, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Breo Ellipta 100/25. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110713/0/Breo_Ellipta_100_25
Vallerand AHA, Sanoski CAC, . Breo Ellipta 100/25 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 January 22]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110713/0/Breo_Ellipta_100_25.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Breo Ellipta 100/25
ID - 110713
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110713/0/Breo_Ellipta_100_25
PB - F.A. Davis Company
ET - 19
DB - Nursing Central
DP - Unbound Medicine
ER -
